Larimar Therapeutics, Inc. (LRMR)
4.79
+0.11
(+2.35%)
USD |
NASDAQ |
Apr 02, 16:00
4.775
-0.02
(-0.31%)
After-Hours: 20:00
Larimar Therapeutics Market Cap : 507.70M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vir Biotechnology, Inc. | 1.452B |
| Gossamer Bio, Inc. | 88.22M |
| ImmunityBio, Inc. | 7.663B |
| BioRestorative Therapies, Inc. | 6.797M |
| Iovance Biotherapeutics, Inc. | 1.403B |
Market Cap Related Metrics
| PEG Ratio | -0.0315 |
| Price to Book Value | 6.372 |
| Price | 4.79 |
| Earnings Yield | -46.09% |
| PEGY Ratio | -0.0315 |